SAVERONE 2014 LTD -ADR (SVRE) Stock Fundamental Analysis

NASDAQ:SVRE • US80516T1051

2.77 USD
-0.06 (-2.12%)
At close: Feb 26, 2026
2.66 USD
-0.11 (-3.97%)
After Hours: 2/26/2026, 5:41:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall SVRE gets a fundamental rating of 3 out of 10. We evaluated SVRE against 124 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of SVRE is average, but there are quite some concerns on its profitability. SVRE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SVRE has reported negative net income.
  • In the past year SVRE has reported a negative cash flow from operations.
  • SVRE had negative earnings in each of the past 5 years.
  • In the past 5 years SVRE always reported negative operating cash flow.
SVRE Yearly Net Income VS EBIT VS OCF VS FCFSVRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • SVRE's Return On Assets of -141.77% is on the low side compared to the rest of the industry. SVRE is outperformed by 92.74% of its industry peers.
  • The Return On Equity of SVRE (-206.83%) is worse than 91.13% of its industry peers.
Industry RankSector Rank
ROA -141.77%
ROE -206.83%
ROIC N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
SVRE Yearly ROA, ROE, ROICSVRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

  • SVRE has a better Gross Margin (38.50%) than 66.13% of its industry peers.
  • SVRE's Gross Margin has improved in the last couple of years.
  • SVRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
SVRE Yearly Profit, Operating, Gross MarginsSVRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SVRE has been increased compared to 1 year ago.
  • SVRE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SVRE has an improved debt to assets ratio.
SVRE Yearly Shares OutstandingSVRE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
SVRE Yearly Total Debt VS Total AssetsSVRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • SVRE has an Altman-Z score of -12.27. This is a bad value and indicates that SVRE is not financially healthy and even has some risk of bankruptcy.
  • SVRE's Altman-Z score of -12.27 is on the low side compared to the rest of the industry. SVRE is outperformed by 84.68% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that SVRE is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.12, SVRE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -12.27
ROIC/WACCN/A
WACC7.52%
SVRE Yearly LT Debt VS Equity VS FCFSVRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • SVRE has a Current Ratio of 3.48. This indicates that SVRE is financially healthy and has no problem in meeting its short term obligations.
  • SVRE has a Current ratio of 3.48. This is in the better half of the industry: SVRE outperforms 71.77% of its industry peers.
  • A Quick Ratio of 2.85 indicates that SVRE has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.85, SVRE is doing good in the industry, outperforming 70.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.48
Quick Ratio 2.85
SVRE Yearly Current Assets VS Current LiabilitesSVRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • SVRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.51%, which is quite impressive.
  • SVRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.19%.
  • SVRE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.69% yearly.
EPS 1Y (TTM)84.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.58%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%56.52%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 194.03% on average over the next years. This is a very strong growth
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year318.52%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SVRE Yearly Revenue VS EstimatesSVRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
SVRE Yearly EPS VS EstimatesSVRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • SVRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SVRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SVRE Price Earnings VS Forward Price EarningsSVRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVRE Per share dataSVRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K -5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SVRE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (2/26/2026, 5:41:08 PM)

After market: 2.66 -0.11 (-3.97%)

2.77

-0.06 (-2.12%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-20
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner Change114.82%
Ins Owners5.23%
Ins Owner ChangeN/A
Market Cap6.05M
Revenue(TTM)1.96M
Net Income(TTM)-34.77M
Analysts80
Price TargetN/A
Short Float %5.68%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)58.59%
EPS NY rev (3m)48.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.58
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-18.58
EYN/A
EPS(NY)-5550.22
Fwd EYN/A
FCF(TTM)-4.96
FCFYN/A
OCF(TTM)-4.95
OCFYN/A
SpS0.29
BVpS2.49
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -141.77%
ROE -206.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.5%
FCFM N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.97%
Cap/Sales 3.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.48
Quick Ratio 2.85
Altman-Z -12.27
F-Score6
WACC7.52%
ROIC/WACCN/A
Cap/Depr(3y)18.53%
Cap/Depr(5y)29.32%
Cap/Sales(3y)4.87%
Cap/Sales(5y)16.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.58%
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.19%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%56.52%
Revenue Next Year318.52%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.81%
OCF growth 3YN/A
OCF growth 5YN/A

SAVERONE 2014 LTD -ADR / SVRE FAQ

Can you provide the ChartMill fundamental rating for SAVERONE 2014 LTD -ADR?

ChartMill assigns a fundamental rating of 3 / 10 to SVRE.


What is the valuation status for SVRE stock?

ChartMill assigns a valuation rating of 0 / 10 to SAVERONE 2014 LTD -ADR (SVRE). This can be considered as Overvalued.


Can you provide the profitability details for SAVERONE 2014 LTD -ADR?

SAVERONE 2014 LTD -ADR (SVRE) has a profitability rating of 1 / 10.